North America proton therapy market is projected to register a CAGR of 6.7% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028
Market Segmentation:
North America Proton Therapy Market, By Product Type (Systems, Software, Services), Component (Proton Accelerator, Beam Transport System, Beam Delivery System, Nozzle, Image Viewers, Patient Positioning System (PPS)), Type (Rotating Proton Therapy Systems, Non Rotating Proton Therapy Systems), Set-Up Systems (Multi-Room Systems, Compact/ Single-Room Systems), Application Type (Treatment Applications, Research Applications), End User (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2028
Some of the major factors contributing to the growth of the North America proton therapy market are:
Growing clinical evidence of the benefit of proton therapy treatment for cancer
Technological advancements in proton therapy
Market Players:
The key market players for North America proton therapy market are listed below:
Varian Medical Systems, Inc.
Protom International
Mevion Medical Systems
Sun Nuclear Corporation
Provision Healthcare
Hitachi, Ltd.
Sumitomo Heavy Industries, Ltd.
Koninklijke Philips N.V.
IBA Worldwide
Elekta AB
Optivus Proton Therapy, Inc.
Advanced Oncotherapy
GENERAL ELECTRIC COMPANY
Best Cyclotron Systems, Inc.
RaySearch Laboratories
PerMedics, Inc.
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PROTON THERAPY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.10 MARKET APPLICATION TYPE COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
5 NORTH AMERICA PROTON THERAPY MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING NUMBER OF PROTON THERAPY CENTERS
6.1.2 INCREASING PREVALENCE OF CANCER
6.1.3 ADVANTAGES OFFERED BY THE PROTON THERAPY TREATMENT IN CANCER
6.1.4 INCREASING FUNDING FOR CANCER RESEARCH
6.1.5 HIGHER AGING POPULATION
6.2 RESTRAINTS
6.2.1 HIGH COST OF INSTALLATION OF INSTRUMENT
6.2.2 LACK OF REIMBURSEMENT
6.3 OPPORTUNITIES
6.3.1 GROWING RECOGNITION OF PROTON THERAPY
6.3.2 INCREASING HEALTHCARE EXPENDITURE
6.3.3 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
6.3.4 INTRODUCTION OF PROTON THERAPY IN EMERGING ECONOMIES
6.4 CHALLENGES
6.4.1 EXPENSIVE TREATMENT AS COMPARED TO OTHER TECHNOLOGIES
6.4.2 REQUIREMENT OF LARGE SPACE
7 COVID-19 IMPACT ON NORTH AMERICA PROTON THERAPY MARKET
7.1 PRICE IMPACT
7.2 IMPACT ON SUPPLY CHAIN
7.3 IMPACT ON DEMAND
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
7.5 CONCLUSION
8 NORTH AMERICA PROTON THERAPY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SYSTEMS
8.2.1 ACCELERATORS
8.2.1.1 CYCLOTRONS
8.2.1.2 SYNCHROTRONS
8.2.2 BEAM DELIVERY
8.2.2.1 PENCIL BEAM SCANNING
8.2.2.2 PASSIVE SCATTERING
8.2.2.3 UNIFORM SCANNING
8.2.3 MODULATORS
8.2.4 OTHERS
8.3 SOFTWARE
8.4 SERVICES
9 NORTH AMERICA PROTON THERAPY MARKET, BY COMPONENT
9.1 OVERVIEW
9.2 PROTON ACCELERATOR
9.2.1 CYCLOTRONS
9.2.2 SYNCHROTRONS
9.2.3 SYNCHROCYCLOTRONS
9.2.4 LINACS
9.2.5 H-MINUS SYNCHROTRONS
9.2.6 SEPARATED SECTOR CYCLOTRONS
9.2.7 SUPER-CONDUCTING CYCLOTRONS
9.2.8 FAST CYCLING SYNCHROTRON
9.3 BEAM TRANSPORT SYSTEM
9.4 BEAM DELIVERY SYSTEM
9.4.1 THE PASSIVE SCATTERING TECHNIQUE
9.4.2 BEAM SCANNING
9.5 NOZZLE
9.5.1 PENCIL SCANNING NOZZLE
9.5.2 SINGLE SCATTERING
9.5.3 DOUBLE SCATTERING
9.5.4 UNIFORM SCANNING NOZZLE
9.6 IMAGE VIEWERS
9.7 PATIENT POSITIONING SYSTEM (PPS)
10 NORTH AMERICA PROTON THERAPY MARKET, BY TYPE
10.1 OVERVIEW
10.2 ROTATING PROTON THERAPY SYSTEMS
10.3 NON ROTATING PROTON THERAPY SYSTEMS
11 NORTH AMERICA PROTON THERAPY MARKET, BY SET-UP SYSTEMS
11.1 OVERVIEW
11.2 MULTI-ROOM SYSTEMS
11.3 COMPACT/ SINGLE-ROOM SYSTEMS
12 NORTH AMERICA PROTON THERAPY MARKET, BY APPLICATION TYPE
12.1 OVERVIEW
12.2 TREATMENT APPLICATIONS
12.2.1 PEDIATRIC CANCER
12.2.2 TUMORS IN THE BASE OF THE SKULL
12.2.3 PROSTATE CANCER
12.2.4 HEAD & NECK CANCER
12.2.5 BREAST CANCER
12.2.6 LUNG CANCER
12.2.7 TUMORS AFFECTING SPINE
12.2.8 EYE MELANOMA
12.2.9 LYMPHOMA
12.2.10 PITUITARY GLAND TUMORS
12.2.11 OTHERS
12.3 RESEARCH APPLICATIONS
13 NORTH AMERICA PROTON THERAPY MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 AMBULATORY SURGICAL CENTERS
13.4 CANCER RESEARCH INSTITUTES
14 NORTH AMERICA PROTON THERAPY MARKET, BY GEOGRAPHY
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
15 NORTH AMERICA PROTON THERAPY MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT
17 COMPANY PROFILE
17.1 IBA WORLDWIDE
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 HITACHI, LTD.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 ELEKTA AB
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 VARIAN MEDICAL SYSTEMS, INC.
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 SUMITOMO HEAVY INDUSTRIES, LTD.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 GENERAL ELECTRIC COMPANY
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENTS
17.7 ADVANCED ONCOTHERAPY
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 BEST CYCLOTRON SYSTEMS, INC.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 KONINKLIJKE PHILIPS N.V.
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.10 MEVION MEDICAL SYSTEMS
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 OPTIVUS PROTON THERAPY, INC.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 PERMEDICS, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 PROTOM INTERNATIONAL
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS
17.14 PROVISION HEALTHCARE
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 RAYSEARCH LABORATORIES
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SUN NUCLEAR CORPORATION
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
Segmentation
Short Description
North America Proton Therapy Market, By Product Type (Systems, Software, Services), Component (Proton Accelerator, Beam Transport System, Beam Delivery System, Nozzle, Image Viewers, Patient Positioning System (PPS)), Type (Rotating Proton Therapy Systems, Non Rotating Proton Therapy Systems), Set-Up Systems (Multi-Room Systems, Compact/ Single-Room Systems), Application Type (Treatment Applications, Research Applications), End User (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2028
Market Definition:
The proton therapy is the most precise and accurate radiation therapy which utilizes the energy of proton particles for killing the cancerous cells or the desired cell at particular location. The major limitations of photon therapy or other particle therapy are overcome by the proton therapy. The advancement in technology has increased the adoption of proton therapy for the treatment of various cancers across globe.
Market Segmentation:
The proton therapy market is categorized into six notable segments which are based on the product type, component, type, set-up systems, application type and end user.
On the basis of product type, the proton therapy market is segmented into systems, software and services
On the basis of component, the proton therapy market is segmented into proton accelerator, beam transport system, beam delivery system, nozzle, image viewers and patient positioning system (PPS)
On the basis of type, the proton therapy market is segmented into rotating proton therapy systems and non rotating proton therapy systems
On the basis of set-up systems , the proton therapy market is segmented into multi-room systems and compact/ single-room systems
On the basis of application type, the proton therapy market is segmented into treatment applications and research applications
On the basis of end user, the proton therapy market is segmented into hospitals, ambulatory surgical centers and cancer research institutes
Market Players
The key market players for North America proton therapy market are listed below:
Varian Medical Systems, Inc.
Protom International
Mevion Medical Systems
Sun Nuclear Corporation
Provision Healthcare
Hitachi, Ltd.
Sumitomo Heavy Industries, Ltd.
Koninklijke Philips N.V.
IBA Worldwide
Elekta AB
Optivus Proton Therapy, Inc.
Advanced Oncotherapy
GENERAL ELECTRIC COMPANY
Best Cyclotron Systems, Inc.
RaySearch Laboratories
PerMedics, Inc.
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
